Newsletter

Watch List for Thursday 3-15-2012 - Email Ad

My new BIG report: BMGP.

Everyone loves the low priced companies, because of their volatility and potential upside. Bio companies generally are very volatile and risky, but investors love them because the rallies can be out of this world.

Unrelated Example: THLD, a bio company just a few months ago was trading at $1.30, today it hit a high of $7.50. That's a gain of 476%!!

BMGP is very low priced and very risky, but I think after you research this company, you will agree BMGP is on the verge of something remarkable!

What do some of the richest people in the world spend their money on? Besides the yachts and endless vacations. Billions of dollars have been spent on eradicating diseases and viruses and billions more will continue to be spent.

What if a product came to market that could quickly diagnosis a disease or virus that normally would of taken weeks? BMGP is working on making this question a reality.

Every second an individual somewhere in the world contracts tuberculosis, and the number of infected individuals may be as many as a third of the global population! Other infectious diseases like human immunodeficiency virus (HIV), malaria, cholera and hepatitis kill millions every year.

The problem is especially acute in Africa, parts of Asia and in Latin America. A significant number of these deaths could greatly be reduced if there were some way to diagnose infections more effectively.

One of the main reasons for the lack of effective diagnostics is that laboratory tests are required for accurate diagnosis. This means sending blood, sputum and skin samples to a lab that is often far from both the patient and the tester.

Most places where infectious diseases run rampant are also grossly short on equipment, staff and facilities for adequate lab work. Some means to field test for viral infections could save millions of lives.

Fortunately, there is a field test device available on the market. A company called Biomagnetics Diagnostics Corporation (BMGP), in cooperation with Los Alamos National Security Laboratory, markets a revolutionary device that tests any body fluid for tuberculosis.

One model of the device is suited for desktop use, but another is a handheld device that practically anybody can operate. Where the primary current diagnostic method, the Western Blot Test, only checks for antibodies, BMGP's device detects the virus itself and is nearly 100 % accurate. It produces test results in as little as 2-3 days while the blot test can take weeks for results!

BMGP is also developing test machines for cholera, HIV, malaria and hepatitis B. Think of the possibilities! On the one hand, millions of lives, including so many children's can be saved!

On the other, such a unique device represents a huge potential for revenue. Some might realistically ask, "How will these developing countries ever afford this kind of investment?"

The answer is simple, they won't have to. Nobody can stand the needless death of children, and developed nations worldwide pump both private and public money in a desperate effort to save lives.

For example, governments worldwide spend billions of dollars to detect and treat infectious diseases in third-world countries. At the private level, just one example includes Bill and Melissa Gates donating, through their Foundation, over $30 million to help develop improved diagnostic testing equipment.

The device developed by BMGP was originally developed by Los Alamos as part of the homeland security effort after 9/11. The machine was designed to help emergency personnel detect bio-hazards while in the field.

Of course it took no time to realize the broader application possibilities. BMGP saw the investment potential and quickly developed a partnership with Los Alamos.

Fifteen year-old BMGP is expanding, both in product line and geography. For example, BMGP is developing a device to help blood banks screen out infected blood.

There currently are tests for these viruses, but they are inefficient and expensive. BMGP has applied for a patent for a machine that tests for eight different viruses and can do it in a fraction of the time.

BMGP is currently partnered with Instituto Mexicana del Seguro Social, the largest institute of its kind in Latin America, to conduct clinical trials. BMGP has also entered into an agreement with a Thailand company, called Bangkok RIA Group, that manufactures and distributes diagnostic products and services.

Few things are more important than diagnosing infectious diseases rapidly and accurately.

This is especially the case in an era where new viral mutations and bioterrorism are very real and potentially catastrophic possibilities.

Do your own research on BMGP at: http://www.biomagneticsbmgp.com Always consult with your own financial professional.

*********************************************************

PLEASE NOTE WELL: This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. BullRally.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. We do no not buy or sell and we do not any receive shares in any of our compensated profiled companies. The disclaimer is to be read and fully understood before using our site, or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. BullRally sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by BullRally Network or an offer or solicitation to buy or sell any security. Viewers should always consult with a licensed securities professional before making any type of investment decision. BullRally.com does not provide trading, investment or tax advice, and readers shall not rely on statements by BullRally.com employees which purport to provide such advice. Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Full disclaimer can be read at http://www.BullRally.com/disclaimer.html

Release of Liability: Through use of this website or email viewing or using you agree to hold BullRally.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. BullRally.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and BullRally.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead BullRally.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. BullRally is compliant with the Can Spam Act of 2003. BullRally does not offer such advice or analysis, and BullRally.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled.

BullRally.com has been compensated by a third party ATG Inc. thirty eight thousand dollars for a one week BMGP advertising services contract. BullRally.com does not own any shares of BMGP. The third party, may have shares and may liquidate it, which may negatively affect the stock price. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company.

All direct and third party compensation received will be disclosed within each individual email in accordance with section 17(b) of the 1 9 3 3 Securities Act. Any compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled companies. BullRally.com has not investigated the background of the third party, the hiring company. Anyone viewing our website and advertisement should assume that the hiring party and affiliates of the hiring party own shares of the profiled company of which they plan to liquidate, further understanding that the liquidation of those shares will most likely impact the share price of the profiled company negatively.

Some of the content in this release contains forward-looking information within the meaning of Section 27 A of the Securities Act of 1 993 and Section 21 E of the Securities Exchange Act of 1 934 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1 995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results. The Private Securities Litigation Reform Act of 1995 provides investors a 'safe harbor' in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.

In preparing this publication, BullRally.com has relied upon information supplied by its customers, public information, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission ("SEC") and the Financial Industry Regulatory Authority ("FINRA"). Investors should use the information contained in this website or email as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, BullRally.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and BullRally Network has no obligation to update any of the information provided. BullRally Network, its owners, officers, directors, contractors and employees are not responsible for errors and omissions. From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website or email. BullRally encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. BullRally.com is not responsible for any claims made by the companies advertised herein, nor is BullRally.com responsible for any other promotional firm, its program or its structure.

By accessing, viewing, or using the website or communications originating from this release, you agree that BullRally, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that BullRally, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. BullRally uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold BullRally, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website or email is at your sole risk. BullRally disclaims all warranties of any kind, express or implied.